Home › Head and Neck Cancer › NCT00230308
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: All patients undergoing surgery at Stanford University for head and neck cancer. Exclusion Criteria: Non-Stanford patients.
About the study
Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.
Sponsor: Stanford University · Participants: 500 · Started: Apr 2, 2002
Contact the study team
- Nikita Bedi · Phone: 650-723-5957
Official record on ClinicalTrials.gov — NCT00230308
Locations in the U.S.
| California | Stanford University School of Medicine, Stanford |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.